Callan Family Office’s Albemarle ALB Stock Holding History

Callan Family Office’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$240K	Sell	1,336 -268	-17%	-$45.8K	0.01%	1000
2025 Q4	$227K	Buy	+1,604	New	+$182K	﹤0.01%	1017

Other funds holding ALB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Callan Family Office's ALB Position: Q1 2026 in Review

Callan Family Office reduced its Albemarle (ALB) stake by 17% in Q1 2026, selling an estimated $45.8K and leaving 1,336 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #1000.

Callan Family Office first reported a position in ALB in Q4 2025 and has held it in 2 quarters since. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

Callan Family Office held 1,336 shares of Albemarle worth $240K as of Q1 2026.
Callan Family Office sold 268 Albemarle shares in Q1 2026, an estimated $45.8K.
Albemarle made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #1000 holding.
Callan Family Office first reported a position in Albemarle in Q4 2025 and has held it in 2 quarters since.
982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.